vs
MERIT MEDICAL SYSTEMS INC(MMSI)とUiPath, Inc.(PATH)の財務データ比較。上の社名をクリックして会社を切り替えられます
UiPath, Inc.の直近四半期売上が大きい($411.1M vs $381.9M、MERIT MEDICAL SYSTEMS INCの約1.1倍)。UiPath, Inc.の純利益率が高く(48.4% vs 10.7%、差は37.6%)。UiPath, Inc.の前年同期比売上増加率が高い(15.9% vs 7.5%)。UiPath, Inc.の直近四半期フリーキャッシュフローが多い($25.1M vs $24.7M)。過去8四半期でMERIT MEDICAL SYSTEMS INCの売上複合成長率が高い(6.3% vs 0.7%)
メリットメディカルシステムズ社はグローバルな医療機器メーカーで、心臓病学、放射線学、腫瘍学、内視鏡検査、救命救護の各分野で使用される介入・診断用製品を開発・製造・販売しています。世界中の病院や医療機関に低侵襲のソリューションを提供し、患者の予後改善と診療効率の向上を支援しています。
UiPath Inc.は人工知能(AI)、自律型オートメーションおよびオーケストレーションソフトウェアを開発するグローバルソフトウェア企業です。同社の製品は複雑な業務プロセスやワークフローを自動化するAIエージェントの構築・管理に対応し、各業界の業務効率向上を支援しています。
MMSI vs PATH — 直接比較
損益計算書 — Q1 FY2026 vs Q3 FY2026
| 指標 | ||
|---|---|---|
| 売上 | $381.9M | $411.1M |
| 純利益 | $41.0M | $198.8M |
| 粗利率 | 48.4% | 83.3% |
| 営業利益率 | 11.6% | 3.2% |
| 純利益率 | 10.7% | 48.4% |
| 売上前年比 | 7.5% | 15.9% |
| 純利益前年比 | 36.0% | 1966.2% |
| EPS(希薄化後) | $0.68 | $0.37 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $381.9M | — | ||
| Q4 25 | $393.9M | $411.1M | ||
| Q3 25 | $384.2M | $361.7M | ||
| Q2 25 | $382.5M | $356.6M | ||
| Q1 25 | $355.4M | $423.6M | ||
| Q4 24 | $355.2M | $354.7M | ||
| Q3 24 | $339.8M | $316.3M | ||
| Q2 24 | $338.0M | $335.1M |
| Q1 26 | $41.0M | — | ||
| Q4 25 | $38.0M | $198.8M | ||
| Q3 25 | $27.8M | $1.6M | ||
| Q2 25 | $32.6M | $-22.6M | ||
| Q1 25 | $30.1M | $51.8M | ||
| Q4 24 | $27.9M | $-10.7M | ||
| Q3 24 | $28.4M | $-86.1M | ||
| Q2 24 | $35.7M | $-28.7M |
| Q1 26 | 48.4% | — | ||
| Q4 25 | 49.6% | 83.3% | ||
| Q3 25 | 48.5% | 82.2% | ||
| Q2 25 | 48.2% | 82.1% | ||
| Q1 25 | 48.4% | 84.8% | ||
| Q4 24 | 48.7% | 82.0% | ||
| Q3 24 | 46.4% | 80.0% | ||
| Q2 24 | 47.7% | 83.5% |
| Q1 26 | 11.6% | — | ||
| Q4 25 | 13.8% | 3.2% | ||
| Q3 25 | 11.1% | -5.6% | ||
| Q2 25 | 12.3% | -4.6% | ||
| Q1 25 | 11.5% | 7.9% | ||
| Q4 24 | 10.3% | -12.2% | ||
| Q3 24 | 11.0% | -32.7% | ||
| Q2 24 | 13.6% | -14.8% |
| Q1 26 | 10.7% | — | ||
| Q4 25 | 9.6% | 48.4% | ||
| Q3 25 | 7.2% | 0.4% | ||
| Q2 25 | 8.5% | -6.3% | ||
| Q1 25 | 8.5% | 12.2% | ||
| Q4 24 | 7.9% | -3.0% | ||
| Q3 24 | 8.4% | -27.2% | ||
| Q2 24 | 10.6% | -8.6% |
| Q1 26 | $0.68 | — | ||
| Q4 25 | $0.64 | $0.37 | ||
| Q3 25 | $0.46 | $0.00 | ||
| Q2 25 | $0.54 | $-0.04 | ||
| Q1 25 | $0.49 | $0.09 | ||
| Q4 24 | $0.46 | $-0.02 | ||
| Q3 24 | $0.48 | $-0.15 | ||
| Q2 24 | $0.61 | $-0.05 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $488.1M | $1.4B |
| 総負債低いほど良い | $735.2M | — |
| 株主資本純資産 | $1.6B | $1.9B |
| 総資産 | $2.7B | $2.9B |
| 負債/資本比率低いほどレバレッジが低い | 0.45× | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $488.1M | — | ||
| Q4 25 | $446.4M | $1.4B | ||
| Q3 25 | $392.5M | $1.4B | ||
| Q2 25 | $341.8M | $1.6B | ||
| Q1 25 | $395.5M | $1.6B | ||
| Q4 24 | $376.7M | $1.6B | ||
| Q3 24 | $523.1M | $1.7B | ||
| Q2 24 | $636.7M | $1.9B |
| Q1 26 | $735.2M | — | ||
| Q4 25 | $734.0M | — | ||
| Q3 25 | $732.9M | — | ||
| Q2 25 | $731.8M | — | ||
| Q1 25 | $730.7M | — | ||
| Q4 24 | $729.6M | — | ||
| Q3 24 | $750.5M | — | ||
| Q2 24 | $801.3M | — |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $1.9B | ||
| Q3 25 | $1.5B | $1.7B | ||
| Q2 25 | $1.5B | $1.7B | ||
| Q1 25 | $1.4B | $1.8B | ||
| Q4 24 | $1.4B | $1.7B | ||
| Q3 24 | $1.3B | $1.8B | ||
| Q2 24 | $1.3B | $2.0B |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $2.9B | ||
| Q3 25 | $2.6B | $2.6B | ||
| Q2 25 | $2.6B | $2.6B | ||
| Q1 25 | $2.5B | $2.9B | ||
| Q4 24 | $2.4B | $2.7B | ||
| Q3 24 | $2.4B | $2.7B | ||
| Q2 24 | $2.4B | $2.8B |
| Q1 26 | 0.45× | — | ||
| Q4 25 | 0.46× | — | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.49× | — | ||
| Q1 25 | 0.51× | — | ||
| Q4 24 | 0.53× | — | ||
| Q3 24 | 0.57× | — | ||
| Q2 24 | 0.62× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | — | $28.3M |
| フリーキャッシュフロー営業CF - 設備投資 | $24.7M | $25.1M |
| FCFマージンFCF / 売上 | 6.5% | 6.1% |
| 設備投資強度設備投資 / 売上 | 4.2% | 0.8% |
| キャッシュ転換率営業CF / 純利益 | — | 0.14× |
| 直近12ヶ月FCF直近4四半期 | $220.8M | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | — | — | ||
| Q4 25 | $98.5M | $28.3M | ||
| Q3 25 | $75.0M | $41.6M | ||
| Q2 25 | $83.3M | $119.0M | ||
| Q1 25 | $40.6M | $146.1M | ||
| Q4 24 | $68.7M | $28.1M | ||
| Q3 24 | $47.3M | $46.4M | ||
| Q2 24 | $68.5M | $100.0M |
| Q1 26 | $24.7M | — | ||
| Q4 25 | $74.0M | $25.1M | ||
| Q3 25 | $52.5M | — | ||
| Q2 25 | $69.6M | $106.2M | ||
| Q1 25 | $19.5M | $138.7M | ||
| Q4 24 | $65.3M | $23.2M | ||
| Q3 24 | $38.0M | $45.0M | ||
| Q2 24 | $57.9M | $98.8M |
| Q1 26 | 6.5% | — | ||
| Q4 25 | 18.8% | 6.1% | ||
| Q3 25 | 13.7% | — | ||
| Q2 25 | 18.2% | 29.8% | ||
| Q1 25 | 5.5% | 32.7% | ||
| Q4 24 | 18.4% | 6.5% | ||
| Q3 24 | 11.2% | 14.2% | ||
| Q2 24 | 17.1% | 29.5% |
| Q1 26 | 4.2% | — | ||
| Q4 25 | 6.2% | 0.8% | ||
| Q3 25 | 5.8% | 0.0% | ||
| Q2 25 | 3.6% | 3.6% | ||
| Q1 25 | 5.9% | 1.7% | ||
| Q4 24 | 1.0% | 1.4% | ||
| Q3 24 | 2.8% | 0.4% | ||
| Q2 24 | 3.1% | 0.4% |
| Q1 26 | — | — | ||
| Q4 25 | 2.59× | 0.14× | ||
| Q3 25 | 2.70× | 26.25× | ||
| Q2 25 | 2.56× | — | ||
| Q1 25 | 1.35× | 2.82× | ||
| Q4 24 | 2.46× | — | ||
| Q3 24 | 1.66× | — | ||
| Q2 24 | 1.92× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
MMSI
セグメントデータなし
PATH
| Subscription Services | $247.6M | 60% |
| License | $150.0M | 36% |
| Professional Services And Other | $13.5M | 3% |